Understanding GLP-1 Drugs
Evidence-based guides on semaglutide, tirzepatide, and other GLP-1 receptor agonists for weight loss and diabetes management.
70 Articles
GLP-1 Medications for Binge Eating Disorder: What the Research Shows
Can semaglutide, liraglutide, or dulaglutide reduce binge eating episodes? A review of pilot trials, mechanisms, and what current evidence means for BED treatment.
Emily Rodriguez
Tirzepatide vs Retatrutide: Which Weight Loss Drug Works Better?
A side-by-side comparison of tirzepatide (Zepbound) and retatrutide based on SURMOUNT, TRIUMPH, and Phase 2 NEJM data — efficacy, safety, mechanism, and timeline.
Dr. Sarah Mitchell
Mazdutide: China's GLP-1/Glucagon Dual Agonist for Obesity
Mazdutide is the world's first approved GLP-1/glucagon dual agonist. GLORY-1 NEJM data, mechanism vs semaglutide, liver fat reduction, and global outlook.
Dr. Sarah Mitchell
GLP-1 Medications and Pregnancy: Safety and Discontinuation
What 2024–2025 research reveals about GLP-1 receptor agonist exposure during pregnancy, washout periods before conception, and clinical management of inadvertent first-trimester exposure.
Dr. Sarah Mitchell
Bariatric Surgery vs GLP-1 Medications: Which Works Better?
Head-to-head data on bariatric surgery vs GLP-1 medications: weight loss percentages, diabetes remission, durability, and how to choose between them.
Dr. Sarah Mitchell
GLP-1 Medications and Sexual Function: What the Research Shows
GLP-1 drugs improve testosterone and erectile function in some men with obesity, but a FAERS signal and clinical reviews flag reduced libido. Here is what the 2025-2026 evidence actually shows.
Dr. Sarah Mitchell
GLP-1 Medications and Alzheimer's Disease: What the Research Shows
Phase 3 EVOKE trials of oral semaglutide failed to slow cognitive decline in early Alzheimer's, but biomarkers improved. Here is what the science actually shows.
Emily Rodriguez
GLP-1 Medications and Gastroparesis: What the Research Shows
Do Ozempic and Wegovy cause stomach paralysis? We review the pharmacovigilance data, gastric emptying studies, FDA labeling, and what it means for safety.
Dr. Sarah Mitchell
GLP-1 Medications and Migraine: What the Research Shows
GLP-1 agonists may reduce migraine frequency and intracranial pressure. We review the exenatide IIH trial, weight loss data, and clinical implications.
Dr. Sarah Mitchell
GLP-1 Medications and Parkinson's Disease: What the Research Shows
A Phase 2 trial of lixisenatide slowed motor decline in early Parkinson's, but the largest Phase 3 study of exenatide found no benefit. Here's what the science says.
Emily Rodriguez
GLP-1 Medications for Adolescents: What the Research Shows
Wegovy and Saxenda are FDA-approved for adolescents 12 and older. Here's what STEP TEENS, AAP guidelines, and ongoing trials reveal about safety and efficacy in teens.
Dr. Sarah Mitchell
GLP-1 Medications for Heart Failure (HFpEF): What the Research Shows
Semaglutide and tirzepatide reduce hospitalizations, ease symptoms, and shrink left ventricular mass in obesity-related HFpEF. Here's what STEP-HFpEF and SUMMIT reveal.
Dr. Sarah Mitchell
GLP-1 Medications and Eye Health: NAION, Retinopathy, and Vision Risks
What 2024–2026 research, the WHO ACSoMP review, and the EMA label update show about Ozempic, Wegovy, and the rare optic-nerve risk known as NAION.
Emily Rodriguez
GLP-1 Medications and Pancreatitis: What the Research Shows
Acute pancreatitis is the safety question most patients ask about Ozempic and Wegovy. Here is what 60+ randomized trials, FDA data, and pharmacovigilance signals actually say in 2026.
Dr. Sarah Mitchell
GLP-1 Medications and Gallbladder Disease: What the Research Shows
Meta-analyses link GLP-1 drugs to a higher risk of gallstones and gallbladder disease. Learn the data, the mechanisms, and how to lower your risk.
Dr. Sarah Mitchell
GLP-1 Medications and Surgery: Perioperative Safety Guide
Should you stop GLP-1 medications before surgery? New 2024–2025 multi-society guidance on aspiration risk, 24-hour liquid diet, and what to tell your anesthesiologist.
Dr. Sarah Mitchell
MariTide (Maridebart Cafraglutide): Amgen's Once-Monthly Obesity Drug
MariTide delivers up to 20% weight loss with monthly dosing. How Amgen's GLP-1 agonist + GIP antagonist works, phase 2 data, and what comes next.
Dr. Sarah Mitchell
GLP-1 Resistance: Why Ozempic Doesn't Work for 1 in 10 People
New 2026 research from Stanford and 23andMe identifies genetic variants that cause GLP-1 resistance — explaining why some patients see minimal weight loss on semaglutide and tirzepatide. Here's the science.
Emily Rodriguez
Survodutide: The Glucagon/GLP-1 Dual Agonist with 16.6% Weight Loss
Boehringer Ingelheim's survodutide hit its Phase 3 SYNCHRONIZE-1 endpoint with 16.6% sustained weight loss — and it does it through a mechanism no approved obesity drug shares. Here's the full evidence.
Dr. Sarah Mitchell
GLP-1 Medications and Menopause: What the Research Shows
Menopause redistributes fat to the abdomen and lowers metabolic rate. Here's what semaglutide and tirzepatide trials show for perimenopausal and postmenopausal women.
Emily Rodriguez
GLP-1 Weight Loss Plateau: Why It Happens and How to Break It
Weight loss on semaglutide and tirzepatide stalls around 12-18 months. Here's the science behind the GLP-1 plateau and evidence-based strategies to restart progress.
Dr. Sarah Mitchell
CagriSema: The First GLP-1 + Amylin Combo for Obesity
Phase 3 REDEFINE 1 data show CagriSema delivers 22.7% weight loss in non-diabetic adults — and an FDA decision is expected in 2026. Here's what the science actually says.
Dr. Sarah Mitchell
GLP-1 Medications and Cancer Risk: What the Research Shows
Recent studies of over 1.6 million patients suggest GLP-1 medications may reduce risk of 10 obesity-associated cancers — but a thyroid signal still demands attention. Here's the evidence.
Dr. Sarah Mitchell
GLP-1 Medications and Joint Pain: What the Research Shows
Discover how GLP-1 medications like semaglutide reduce joint pain in osteoarthritis and rheumatoid arthritis. Review of landmark clinical trials and mechanisms.
Dr. Sarah Mitchell
GLP-1 Medications and Type 2 Diabetes Remission
Can GLP-1 receptor agonists like semaglutide and tirzepatide induce type 2 diabetes remission? A review of the latest clinical evidence and what it means for patients.
Dr. Sarah Mitchell
Orforglipron: The Oral GLP-1 Pill for Weight Loss
Orforglipron is Eli Lilly's oral small-molecule GLP-1 receptor agonist. Phase 3 trials show up to 11.2% weight loss — no injections required. Here's what the science says.
Dr. Sarah Mitchell
Retatrutide: Triple-Agonist Drug with 24% Weight Loss
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, producing 24.2% weight loss in Phase 2 trials — beyond any current obesity drug.
Dr. Sarah Mitchell
Oral Semaglutide for Weight Loss: The New Wegovy Pill
The FDA-approved Wegovy pill delivers up to 16.6% weight loss in clinical trials. Learn how oral semaglutide works, how it compares to injections, and who it's right for.
Dr. Sarah Mitchell
GLP-1 Medications and Addiction: What the Research Shows
Emerging research reveals GLP-1 medications like semaglutide may reduce cravings for alcohol, opioids, and nicotine by targeting the brain's reward system. Here's what the science shows.
Dr. Sarah Mitchell
GLP-1 Medications and Insulin Resistance: What the Research Shows
How GLP-1 receptor agonists like semaglutide and tirzepatide reverse insulin resistance through hepatic, muscular, and adipose mechanisms — with clinical trial evidence.
Dr. Sarah Mitchell
GLP-1 Medications and Cholesterol: What the Research Shows
GLP-1 medications like semaglutide and tirzepatide improve cholesterol and triglycerides. Here's what clinical trials reveal about their lipid-lowering effects.
Dr. Sarah Mitchell
GLP-1 Medications and Fertility: What the Research Shows
Growing evidence links GLP-1 receptor agonists to improved fertility in women with PCOS and obesity. What 2024–2025 research reveals about safety, efficacy, and pregnancy planning.
Dr. Sarah Mitchell
GLP-1 Medications and Blood Pressure: What the Research Shows
How semaglutide and tirzepatide lower blood pressure through weight loss and direct vascular mechanisms — a review of the latest clinical trial evidence.
Emily Rodriguez
GLP-1 Medications and Thyroid Health: What the Research Shows
GLP-1 receptor agonists carry an FDA thyroid warning, but human evidence differs sharply from rodent data. Here's what clinical trials actually show about thyroid cancer risk and thyroid function.
Dr. Sarah Mitchell
GLP-1 Medications and Skin Health: What the Research Shows
GLP-1 receptor agonists like semaglutide may improve psoriasis and hidradenitis suppurativa, but also cause 'Ozempic face' and skin laxity. Here's what the evidence shows.
Dr. Sarah Mitchell
GLP-1 Medications and Inflammation: What the Research Shows
Beyond weight loss, GLP-1 medications like semaglutide reduce systemic inflammation through multiple pathways. Here's what clinical trials and mechanistic studies reveal.
Dr. Sarah Mitchell
GLP-1 Medications and Gut Health: What the Research Shows
How GLP-1 receptor agonists like semaglutide and tirzepatide affect gut microbiome diversity, intestinal barrier function, and inflammatory conditions — a review of the latest science.
Dr. Sarah Mitchell
GLP-1 Medications and Mental Health: What the Research Shows
Do GLP-1 medications like semaglutide affect depression, anxiety, and addiction? A review of the latest clinical research on psychiatric safety and brain health.
Emily Rodriguez
GLP-1 Medications and Hair Loss: What the Research Shows
Hair loss affects many GLP-1 users. Learn what the science says about why it happens, who is most at risk, and evidence-based strategies to minimize shedding.
Dr. Sarah Mitchell
GLP-1 Medications and Bone Health: What the Research Shows
GLP-1 medications may reduce bone mineral density during weight loss. Learn what clinical research reveals about fracture risk and how to protect your bones.
Dr. Sarah Mitchell
GLP-1 Medications and Brain Health: What the Research Shows
New research links semaglutide and other GLP-1 drugs to reduced dementia risk and neuroprotection. Here's what the science actually says about brain health.
Dr. Sarah Mitchell
GLP-1 Medications and Kidney Health: What the Research Shows
Learn how GLP-1 receptor agonists like semaglutide protect kidney function, reduce albuminuria, and slow CKD progression — backed by the landmark FLOW trial and 2024 meta-analyses.
Dr. Sarah Mitchell
GLP-1 Medications and Fatty Liver Disease: What the Research Shows
New phase 3 trials show semaglutide resolves MASH in 63% of patients. Learn how GLP-1 medications treat MASLD, what the research reveals, and when they may help.
Dr. Sarah Mitchell
GLP-1 Medications for PCOS: What the Research Shows
GLP-1 receptor agonists like semaglutide and liraglutide show promising results for PCOS—improving insulin resistance, reducing androgens, and restoring menstrual cycles.
Dr. Sarah Mitchell
What Is Food Noise? How GLP-1 Medications Help Silence It
Food noise is the relentless mental chatter about food that drives overeating. Learn how GLP-1 medications like semaglutide reduce this cognitive burden scientifically.
Dr. Sarah Mitchell
GLP-1 Medications and Sleep Apnea: What the Research Shows
Tirzepatide became the first FDA-approved drug for obstructive sleep apnea in 2024. Learn what clinical trials reveal about GLP-1 medications and OSA.
Dr. Sarah Mitchell
GLP-1 Medications and Alcohol: What the Research Shows
GLP-1 drugs like Ozempic may reduce alcohol cravings and intake. Explore the clinical evidence, neurobiological mechanisms, and practical safety guidance.
Dr. Sarah Mitchell
GLP-1 Medications and Muscle Loss: How to Preserve Lean Mass
GLP-1 drugs like semaglutide can cause lean mass loss alongside fat loss. Learn what clinical trials show and how resistance training and protein intake preserve muscle.
Dr. Sarah Mitchell
GLP-1 Medications and Heart Health: Cardiovascular Benefits Beyond Weight Loss
GLP-1 receptor agonists like semaglutide and liraglutide reduce major cardiovascular events, stroke, and heart failure risk—independent of weight loss alone. Here's what the evidence shows.
Emily Rodriguez
Tirzepatide vs Semaglutide: Which Is More Effective for Weight Loss?
A clinical comparison of tirzepatide (Zepbound/Mounjaro) and semaglutide (Wegovy/Ozempic) for weight loss, based on the SURMOUNT-5 trial and real-world evidence.
Dr. Sarah Mitchell
Weight Regain After Stopping GLP-1 Medications: What Research Shows
Most people regain two-thirds of lost weight within one year of stopping GLP-1 drugs. Landmark trials on semaglutide and tirzepatide explain why, and what to do about it.
Dr. Sarah Mitchell
Diet vs Medication for Weight Loss: What the Evidence Shows
A science-based comparison of dietary interventions vs GLP-1 medications for weight loss, including which approach works better and when to combine both.
Emily Rodriguez
Exercise with GLP-1 Medications: Preserving Muscle
Learn how to combine exercise with GLP-1 medications like semaglutide and tirzepatide to maximize fat loss, preserve lean muscle mass, and improve long-term outcomes.
Dr. Sarah Mitchell
Phentermine vs GLP-1 Medications: Which Is Right for You?
Compare phentermine and GLP-1 receptor agonists for weight loss. Evidence-based breakdown of efficacy, safety, cost, and how to choose between these two drug classes.
Dr. Sarah Mitchell
Bydureon vs Victoza: Which GLP-1 Is Right for You?
A science-backed comparison of Bydureon (exenatide ER) vs Victoza (liraglutide): HbA1c reduction, weight loss, cardiovascular outcomes, and side effects.
Dr. Sarah Mitchell
Trulicity vs Ozempic: A Clinical Comparison for 2026
Trulicity vs Ozempic: compare efficacy, weight loss, cardiovascular outcomes, side effects, and cost in this evidence-based clinical guide with 6 scientific citations.
Emily Rodriguez
How to Switch Between GLP-1 Medications Safely
A clinical guide to switching between GLP-1 receptor agonists — when to switch, how to transition, and what outcomes to expect based on current evidence.
Dr. Sarah Mitchell
Missed Dose Protocol for GLP-1 Medications: What to Do
Learn exactly what to do if you miss a dose of semaglutide, tirzepatide, or liraglutide — with evidence-based guidelines and pharmacokinetic data.
Dr. Sarah Mitchell
Traveling with GLP-1 Medications: The Complete Guide
How to travel safely with Ozempic, Wegovy, and Mounjaro — covering storage, TSA rules, injection schedules, and managing GI side effects on the road.
Dr. Sarah Mitchell
Rybelsus (Oral Semaglutide): Complete Guide to the Pill Form
Rybelsus is the first oral GLP-1 medication for type 2 diabetes and weight loss. Learn how it works, dosing, efficacy, side effects, and how it compares to injections.
Dr. Sarah Mitchell
Saxenda vs Wegovy: Which GLP-1 Wins for Weight Loss?
Head-to-head comparison of Saxenda (liraglutide 3mg) vs Wegovy (semaglutide 2.4mg) for weight loss, based on the STEP 8 trial and systematic reviews.
Dr. Sarah Mitchell
Ozempic Off-Label Use: What the Science Says
Discover the evidence behind Ozempic's off-label uses for cardiovascular disease, kidney disease, PCOS, liver disease, and alcohol use disorder.
Emily Rodriguez
Wegovy Dosing Schedule: Complete Step-by-Step Guide
The complete Wegovy (semaglutide 2.4mg) dosing schedule: from 0.25mg starter dose to maintenance, with clinical evidence on titration, side effects, and missed doses.
Dr. Sarah Mitchell
Semaglutide Dosage Guide: Titration, Maintenance & Adjustments
Complete semaglutide dosage guide covering titration schedules for Wegovy, Ozempic, and Rybelsus — with clinical evidence, dose adjustment tips, and missed dose protocols.
Dr. Sarah Mitchell
Mounjaro vs Ozempic: A Science-Based Comparison for Weight Loss
Head-to-head clinical trial data comparing tirzepatide (Mounjaro) vs semaglutide (Ozempic) for weight loss and diabetes management. Evidence-based analysis of efficacy, side effects, and real-world outcomes.
Dr. Sarah Mitchell
Tirzepatide (Mounjaro): O Primeiro Agonista Dual GIP/GLP-1
Guia completo sobre tirzepatide - mecanismo dual de ação, eficácia superior ao semaglutide nos estudos SURPASS, efeitos colaterais e protocolo de dosagem
Dr. Sarah Mitchell
Liraglutide (Saxenda & Victoza): Complete Guide
Everything you need to know about liraglutide — how it works, dosing, side effects, and how it compares to newer GLP-1 medications like semaglutide and tirzepatide.
Emily Rodriguez
GLP-1 Medication Side Effects: What You Need to Know
Comprehensive guide to GLP-1 medication side effects including semaglutide, tirzepatide, and liraglutide. Learn about common, rare, and serious adverse effects.
Emily Rodriguez
Ozempic vs Wegovy: What's the Difference?
Compare Ozempic and Wegovy—two semaglutide medications. Learn about dosages, approved uses, insurance coverage, and which might be right for you.
Dr. Sarah Mitchell
What is Semaglutide? A Complete Guide to This Revolutionary Weight Loss Medication
Learn everything about semaglutide, how it works for weight loss, its effectiveness, side effects, and what to expect when starting treatment.
Dr. Sarah Mitchell